跳至主要内容
临床试验/NCT05051631
NCT05051631已完成不适用

BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity

Vanderbilt University Medical Center2 个研究点 分布在 1 个国家目标入组 1,071 人开始时间: 2022年3月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,071
试验地点
2
主要终点
Number of Eligible Women Who Received Breast Cancer Risk Assessment

研究概览

简要总结

The central goal of this study is to test strategies to implement evidence-based breast cancer risk assessment in healthcare clinics in Tennessee. The BRAVE Strategy (Breast cancer Risk Assessment - achieVing Equity) study aims to assess the feasibility, reach, acceptability, and appropriateness of select customized strategies to increase uptake of breast cancer risk assessment. The investigators will achieve these aims through a conducting a stepped-wedge trial conducted in 10 healthcare clinics in the state of Tennessee. The primary outcome is the proportion of women age 25-49 having risk assessment. Secondary outcomes include the numbers of 1) women identified as high-risk; 2) pursuing risk-adherent screening; and 3) diagnosed with breast cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
25 Years 至 49 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • ages 25-49

排除标准

  • personal history of breast cancer

结局指标

主要结局

Number of Eligible Women Who Received Breast Cancer Risk Assessment

时间窗: Baseline (2-months prior to intervention) to 9 months post-intervention

The number of women eligible for risk assessment who received documented breast cancer risk assessment.

次要结局

  • Number of Cancers Detected in Women Identified at High Risk.(Baseline (2-months prior to intervention) to 9 months post-intervention)
  • Number of Women Who Received Risk Assessment Who Were Identified as High Risk for Breast Cancer.(Baseline (2-months prior to intervention) to 9 months post-intervention)
  • Number of Women Identified as High Risk Women Who Received Breast Cancer Screening.(Baseline (2-months prior to intervention) to 9 months post-intervention)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lucy Spalluto

Associate Professor of Radiology and Radiological Sciences

Vanderbilt University Medical Center

研究点 (2)

Loading locations...

相似试验